CACrown ArchivesThe cinema collection
EN/FR
Search
Menu
Research dossier · General Reference

A-CHMINACA

synthetic cannabinoid

Cross-disciplinary reference desk with index cards, atlas, dictionary and catalogue
General referenceInterpretive dossier study · Crown Archives visual atlas
Record originEnglish Wikipedia
Text licenseCC BY-SA 4.0
Source revisionMay 20, 2026
Entity authorityQ136373262 ↗
Source-derived summary

A-CHMINACA, (ACHMINACA, Adamantyl-CHMINACA, SGT-37), is an indazole-based synthetic cannabinoid that binds to the CB1 and CB2 receptors.

It has an EC50 of 159 nM for human CB1 receptors.

Metabolism

A-CHMINACA is not hydrolized by human carboxylesterases which increases its half-life.

Distribution

A-CHMINACA has been sold as a designer drug with one sample having been seized by Polish authorities in Lublin.

It was also detected in samples taken in Toronto in 2020.

Editorial summary

Begin with the source’s own compact description: “A-CHMINACA” is synthetic cannabinoid. The dossier treats that line as a proposition to test through A-CHMINACA, synthetic and cannabinoid, not as a finished interpretation.

Editorial reviewA practical starting point whose main value is the path it opens into stronger specialist and primary sources. The current lead gives the account dated anchors—2020—that can be checked directly. The selected authority fields contribute no independent date. For this dossier, A-CHMINACA, synthetic and cannabinoid is the immediate research focus.
Editorial analysis

Why this record matters

The phrase “synthetic cannabinoid” supplies a clear boundary for inquiry. It also exposes the unanswered questions: who defined that boundary, when it became stable and which sources sit outside it.

Evidence profile

The citation trail is more important than the brevity of the summary: it shows where individual claims can be examined in context. The source revision retrieved here is dated May 20, 2026. The linked authority identifier is Q136373262. None of the 0 selected statements returned an explicit reference. The first chronological checks are 2020.

Critical limits

A concise general-reference account can conceal disagreements about scope, terminology or the weight assigned to individual sources. The lead is largely declarative, so disagreement and counter-evidence require a deliberate search beyond the opening account. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.

How to read it

Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.

Best used for
  • Subject orientation
  • Search vocabulary
  • Locating named sources
Verify next

The closest primary source, responsible institution and strongest cited specialist reference.

Three-step research path

  1. Establish the record: confirm the title “A-CHMINACA”, its source revision and the description used here.
  2. Expand the search: follow A-CHMINACA primary sources, A-CHMINACA archive and A-CHMINACA research across catalogues and specialist indexes.
  3. Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.

Questions for further research

  1. Which source most directly establishes the central claim about “A-CHMINACA”?
  2. Which institution is responsible for the underlying evidence?
  3. Which cited source is closest to the event, object or claim?
Subject index

Search terms from this dossier

Source & attribution

This entry incorporates text from “A-CHMINACA” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.